Pathway Therapeutics

- PRIVATE:PATHWAYTHERAPEUTICS

Pathway Therapeutics develops selective inhibitors of PI3-kinase and mTOR for the treatment of cancer and inflammatory diseases.
- pathwaytx.com
Locations
- San Francisco CA
Total Funding (USD)
24.0 million

Filter date

Bookmark	Created by	Last updated
There were no results found.

Filter date

Article	Author	Published
There were no results found.

Request a demo to view additional historical data, and much more.